AIM: The discussion in Germany about the reimbursement of the 18F-fluorodeoxyglucose Positron-Emissiontomography (FDG-PET) in oncology should make use of the experience from the other European countries. METHOD: A questionnaire was sent to 23 PET-institutions in Europe, outside from Germany, in January 2003...
Keywords: PET, Vergütung, Europa
01/2003 | Nuklearmedizin, Schattauer